NCT02018380

Brief Summary

Osteoarthritis (OA) is a progressive, chronic disease affecting more than 20 million Americans. There is no known cure for OA and management includes pain control and prevention of functional decline. Purpose: To investigate the immediate effects of a shock absorbing insole (SAI) placed in the shoe on knee pain, functional mobility and lower extremity biomechanics.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P50-P75 for phase_2

Timeline
Completed

Started Aug 2006

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2006

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2008

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2008

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

June 29, 2009

Completed
4.5 years until next milestone

First Posted

Study publicly available on registry

December 23, 2013

Completed
Last Updated

December 23, 2013

Status Verified

December 1, 2013

Enrollment Period

1.8 years

First QC Date

June 29, 2009

Last Update Submit

December 16, 2013

Conditions

Outcome Measures

Primary Outcomes (1)

  • Knee pain while walking

    Baseline

Secondary Outcomes (3)

  • Ground Reaction Forces

    Baseline

  • Knee joint kinetics during stance phase of gait

    Baseline

  • Gait speed

    Baseline

Study Arms (1)

Shock Absorbing Insoles vs. Athletic shoes

EXPERIMENTAL
Other: Shock Absorbing Insole (SofSole Athletes Plus)

Interventions

The shock absorbing insole used in this study was the SofSole Athletes Plus, (Implus Inc, Durham, NC), recommended by the manufacturer for repetitive activities such as running and walking. It is readily available in most athletic shoe stores, retailing for under $20.00. The insole is full-length with a curved last made of Implus XP that has a shore A durometer reading of 60 (0 = softest to 100 = hardest).

Also known as: SofSole Athletes Plus
Shock Absorbing Insoles vs. Athletic shoes

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years of age or older
  • Radiographic evidence of knee OA in the test extremity (K-L grading scale = 1 to 4)
  • Knee pain (WOMAC pain subscore of 4 or more and report moderate pain on at least 1 listed activity in the WOMAC) on most days
  • Able to speak, write, and understand English
  • Able to walk 25 feet without an assistive device
  • Must wear a shoe size available in the lab (Women's 6-10 and Men's 8-14)
  • Able to attend two sessions of data collection within 14 days

You may not qualify if:

  • Currently wearing some type of foot orthosis (custom or over-the counter)
  • Had lower extremity surgery of the test leg in the past 12 months
  • Had a total knee replacement on the involved leg
  • Had hip and/or ankle OA in the involved leg
  • Had a neuromuscular disease disorder which affected their walking ability

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Winston Salem State University

Winston-Salem, North Carolina, 27110, United States

Location

MeSH Terms

Conditions

Osteoarthritis

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Study Officials

  • Judy L Foxworth, PT, PhD

    Winston Salem State University

    PRINCIPAL INVESTIGATOR
  • Darin Padua, ATC, PhD

    Unversity of North Carolina

    STUDY CHAIR
  • Stephen Messier, PhD

    Wake Forest University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

June 29, 2009

First Posted

December 23, 2013

Study Start

August 1, 2006

Primary Completion

May 1, 2008

Study Completion

July 1, 2008

Last Updated

December 23, 2013

Record last verified: 2013-12

Locations